Additional archives available: NHF Features
TorreyPines Therapeutics has reported that pharmacokinetic data obtained in a Phase I maximum tolerated dose clinical trial of NGX426, the oral prodrug of tezampanel...
For some migraine sufferers, there may be a new way to prevent the horrible headaches without drugs. Health Watch reporter Nesita Kwan showed how one patient does it by exercising her mind...
Use of preventive therapy for migraine is often recommended for only 6–9 months, but no randomised, placebo-controlled trials have investigated migraine frequency after the end of prophylaxis...
Your donation goes to work immediately, helping the NHF in our continuing effort to educate and fund valuable headache research.
“I do greatly enjoy the NHF Newsletter. It has been a blessing to me to realize I’m not alone and that others are working hard to help those of us who suffer.”
